2018 in review: How patient centricity led to new drugs that tackle unmet need

The trend for working with patients, advocacy groups and appraisal authorities has yielded potentially life-changing results for patient centricity in 2018.

It was a year of new hope for millions of people living with underserved conditions, as the pharmaceutical industry made huge strides towards tackling unmet need.

Collaboration, innovative trial design and listening to the patient voice have led to a slew of proposals, trials and even approvals of medicines for all-too-often forgotten conditions.